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and characterized by visceral invasion. Degradation of the extracellular matrix by matrix metalloproteinases
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identiﬁed in HTLV-1-infected T-cell lines, peripheral blood ATL cells and ATL cells in lymph nodes, but not in
uninfected T-cell lines or normal peripheral blood mononuclear cells. MMP-7 expression was induced following
infectionof a humanT-cell linewithHTLV-1, and speciﬁcally by the viral protein Tax. Functionally,MMP-7promoted
cellmigrationofHTLV-1-infectedTcells. TheMMP-7promoter activitywas increasedbyTaxand reducedbydeletion
of the activator protein-1 (AP-1) binding site. Electrophoreticmobility shift assay showedhigh levels of AP-1binding
proteins, including JunD, in HTLV-1-infected T-cell lines and ATL cells, and Tax elicited JunD binding to the MMP-7
AP-1 element. Tax-induced MMP-7 activation was inhibited by dominant negative JunD and augmented by JunD/
JunDhomodimers. Short interfering RNA against JunD inhibitedMMP-7mRNA expression inHTLV-1-infected T-cell
lines. These results suggest that the induction ofMMP-7 by Tax is regulated by JunD and thatMMP-7 could facilitate
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Human T-cell leukemia virus type 1 (HTLV-1) infection causes
adult T-cell leukemia (ATL) [1]. ATL is an aggressive malignancy of
mature activated T cells characterized by frequent visceral invasion by
tumor cells [2]. Vascular inﬁltration of tumor cells through the
endothelial cells is a critical step of cancer invasion and metastasis,which is an important prognostic factor of malignant diseases. In this
process of neoplasm inﬁltration, there is increased production of
matrix metalloproteinases (MMPs) from tumor cells [3]. Degradation
of the extracellular matrix byMMPs is a crucial step in tumor invasion
and metastasis [4]. Indeed, HTLV-1-infected T-cell lines and primary
ATL cells secrete high levels of MMP-9, and a signiﬁcant elevation of
plasmaMMP-9 was observed in some ATL patients, particularly in the
patients with ATL cell inﬁltration [5]. In addition, ATL cells express
extracellular MMP inducer, emmprin, a cell surface inducer of MMPs
that stimulates nearby ﬁbroblasts to produce MMP-2 [6].
The MMP family consists of at least 25 zinc-dependent endopep-
tidases. Almost all MMPs share homologous protein sequences and
domain structures. In addition to these conserved domains, MMPs
have diverse domains that are related to substrate speciﬁcity and
recognition of other proteins. However, MMP-7 (matrilysin), MMP-23
and MMP-26 lack the C-terminal hemopexin domain common to
other MMPs members, and they have distinctively smaller molecular
weights [3]. Although the majority of MMPs are produced predom-
inantly by stromal cells, such as stromal ﬁbroblasts, macrophages and
endothelial cells, only a few MMPs, including MMP-7, are expressed
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tumor-associated fashion. MMP-7 is overexpressed in various epi-
thelial tumors and mesenchymal tumors. The production by tumor
cells themselves could be useful as a biological marker of an
aggressive phenotype and as a target of therapeutic intervention [3].
The expression ofMMP-7 inATL has not been examinedpreviously.
In this study, we investigated the expression of MMP-7 in various T-
cell lines and clinical samples fromATL patients.We exploredwhether
MMP-7 expression could be induced by the HTLV-1 oncogene Tax. The
results demonstrated that JunD, a member of the activator protein-1
(AP-1) family [7], plays a major role in MMP-7 expression in ATL cells.
2. Materials and methods
2.1. Cell lines
HTLV-1-infected T-cell lines,MT-2 [8], SLB-1 [9], MT-1 [10], TL-OmI
[11] and HLN-ATL-O [12], and HTLV-1-uninfected T-cell lines, Jurkat,
MOLT-4, CCRF-CEM and TY8-3 [13], were cultured in RPMI 1640
medium supplemented with 10% heat-inactivated fetal bovine serum
(FBS; Biological Industries, Kibbutz Beit Haemek, Israel), 50 U/ml
penicillin and 50 μg/ml streptomycin. MT-2 and SLB-1 are HTLV-1-
transformed T-cell lines and constitutively express viral genes. MT-1
and TL-OmI are T-cell lines of leukemic cell origin that were
established from patients with ATL, and do not express viral genes.
HLN-ATL-Owas also established from a patient with ATL, but its clonal
origin is unclear. TY8-3/MT-2 was established from the interleukin
(IL)-2 dependent human T-cell line TY8-3 cocultured with mitomycin
C-treated MT-2 cells and was capable of growth completely indepen-
dent of IL-2 [13]. JPX-9 is a subline of Jurkat that expresses Tax, under
the control of themetallothionein gene promoter [14]. Peripheral blood
mononuclear cells (PBMCs) were isolated from 3 healthy volunteers
and 9 patientswith acute type ATL, using Ficoll-Paque density gradient
centrifugation (GE Healthcare Biosciences, Uppsala, Sweden). To use
activated T cells, PBMCs were stimulated with 10 μg/ml phytohemag-
glutinin (PHA) for 48 h. All samples were collected at the time of
admission to the hospital before the commencement of chemother-
apy. The diagnosis of ATLwas based on clinical features, hematological
ﬁndings and the presence of anti-HTLV-1 antibodies in the serum.
Monoclonal HTLV-1 provirus integration into the DNA of leukemic
cellswas conﬁrmedby Southern blot hybridization in all patients (data
not shown). This study was approved by the Institutional Review
Board of theUniversity of the Ryukyus. Informed consentwas obtained
from all blood and tissue donors according to the Helsinki Declaration.
2.2. Reagents
Rabbit polyclonal antibody and mouse monoclonal antibody to
MMP-7 were purchased from Chemicon International (Temecula, CA,
USA) and Daiichi Fine Chemical (Takaoka, Japan), respectively. Mouse
monoclonal antibody to actin was from NeoMarkers (Fremont CA,
USA). Rabbit polyclonal antibodies to JunD, phospho-c-Jun (Ser73),
phospho-JunD (Ser100), c-Jun NH2-terminal kinase (JNK) and phos-
pho-JNK (Thr183 and Tyr185), and rabbit monoclonal antibodies to
extracellular signal-regulated kinase (ERK)1/2 and phospho-ERK1/2
(Thr202 and Tyr204) were purchased from Cell Signaling Technology
(Beverly, MA, USA). Antibody to Tax, Lt-4, was described previously
[15]. JNK inhibitor SP600125 and mitogen-activated protein kinase/
ERK kinase1/2 inhibitor PD98059 were obtained from Calbiochem (La
Jolla, CA, USA). Phorbol 12-myristate 13-acetate (PMA) and ionomycin
were purchased from Sigma-Aldrich (St. Louis, MO, USA).
2.3. Reverse transcription-PCR (RT-PCR)
Total cellular RNA from cells was extracted with Trizol (Invitrogen,
Carlsbad, CA, USA) according to the protocol provided by themanufacturer. First-strand cDNAwas synthesized from1 μg total cellular
RNA using an RNA-PCR kit or a PrimeScript RT-PCR kit (Takara Bio Inc.,
Otsu, Japan) with random primers. The primers used were 5′-GATC-
TCAAATGAGTCACCTAT-3′ (forward) and 5′-GATCATAGGTGACT-
CATTTGA-3′ (reverse) for MMP-7, 5′-CCGGCGCTGCTCTCATCCCGGT-3′
(forward) and 5′-GGCCGAACATAGTCCCCCAGAG-3′ (reverse) for Tax,
5′-CGCAGCCTCAAACCCTGCCTTTCC-3′ (forward) and 5′-CAAACA-
GGAATGTGGACTCGTAGC-3′ (reverse) for JunD, and 5′-GTGGG-
GCGCCCCAGGCACCA-3′ (forward) and 5′-CTCCTTAATGTCA-
CGCACGATTTC-3′ (reverse) for β-actin. The length of the semiquanti-
tative RT-PCR for each gene was as follows; 35 cycles for MMP-7, 30
cycles for Tax, 40 cycles for JunD, and 28 cycles for β-actin. The PCR
products were fractionated on 2% agarose gels and visualized by
ethidium bromide staining. The obtained bands of ampliﬁed DNA were
quantiﬁed using AlphaEase FC software (Alpha Innotech Corporation,
San Leandro, CA,USA). Datawere normalized toβ-actin loading controls.
2.4. Western blot analysis
Cells were lysed in a buffer containing 62.5 mM Tris–HCl (pH 6.8),
2% sodium dodecyl sulfate, 10% glycerol, 6% 2-mercaptoethanol and
0.01% bromophenol blue. Equal amounts of protein (20 μg) were
subjected to electrophoresis on sodium dodecyl sulfate-polyacryl-
amide gels, followed by transfer to a polyvinylidene diﬂuoride
membrane and sequential probing with the speciﬁc antibodies. The
bands were visualized with an enhanced chemiluminescence kit
(Amersham Biosciences, Piscataway, NJ, USA).
2.5. Immunohistochemical analysis
Biopsy samples were taken from the lymph nodes of 6 patients with
ATL. In addition, 2 specimens of normal lymph nodes were included.
Serial sections were deparafﬁnized in xylene and dehydrated using
graded ethanol solutions. For better detection, sections were pretreated
with ready-to-use proteinase K (Dako Inc., Carpinteria, CA, USA) for
10 min at 37 °C. This procedure increased the number of antigenic sites
available for binding by the antibody. Sections were washed 4 times in
phosphate-buffered saline (PBS) for 5 min each. In the next step, the
tissues were placed in 3% hydrogen peroxide and absolutemethanol for
5 min to reduce endogenous peroxidase activity, followed by 4 washes
in PBS, 5 min each. The tissue sections were incubated with the
polyclonal rabbit anti-MMP-7 antibody for 3 h at 37 °C. After 4 washes
with PBS, 5 min each, the sections were covered with EnVision plus
(Dako Inc., Santa Barbara, CA, USA) for 40 min at 37 °C and washed 4
times in PBS, 5 min each. Antigenic sites bound by the antibody were
identiﬁed by reacting the sections with a mixture of 0.05% 3,3′-
diaminobenzidine tetrahydrochloride in 50 mM Tris–HCl buffer and
0.01% hydrogen peroxide for 7 min. Sections were washed 3 times in
distilled water, 5 min each, and then counterstained with methyl green
for 10 min, hydrated in ethanol, cleaned in xylene and mounted. The
stained cells were examined using a light microscope.
2.6. Immunoﬂuorescence staining
Cells were ﬁxed with 4% paraformaldehyde for 20 min at 37 °C.
Fixed cells were washed with PBS containing 7% of FBS twice and
permeabilized with PBS containing 0.1% Triton X-100 for 10 min at
room temperature. The cells were washed with PBS containing 7% of
FBS once and resuspended in PBS/7% FBS containing mouse anti-
MMP-7 monoclonal antibody or rabbit anti-MMP-7 polyclonal
antibody for 20 min at room temperature. The cells were washed
with PBS/7% FBS twice and resuspended in PBS/7% FBS containing
Alexa Fluor 488-labeled goat anti-mouse IgG or Alexa Fluor 546-
labeled goat anti-rabbit IgG (Invitrogen, Carlsbad, CA, USA) for 20 min
at room temperature. The nuclei were stained with Hoechst 33342
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washed with PBS twice and observed under a confocal microscope.
2.7. Transfection and luciferase assay
A series of expression vectors for Tax (pβMT-2 Tax) and its
mutants (Tax M22 and Tax 703) were described previously [16]. The
expression vector (DN-JunD) for dominant negative JunD lacking
amino acids 1–162 and the mutant JunD expression vector (JunD/
S100A) encoding a modiﬁed JunD protein in which the Ser100 residue
has been replaced by Ala have been described previously [17,18]. In
the JunD/EB1 vector, the dimerization domain of wild type JunD is
replaced by the heterologous homodimerization domain of the
Epstein–Barr virus transcription factor EB1 and binds DNA exclusively
as a homodimer [19]. The −296HMAT-Luc parental construct was
generated by inserting theMMP-7 promoter region (−296 to+35 bp
surrounding the transcription start site) into the pGL2-basic vector
(Promega, Madison, WI, USA) [20]. Inactivating mutations were
introduced into two Tcf sites of the−296HMAT-Luc reporter to create
Mut(−194/−109Tcf) reporter [20]. The Del(−67AP-1) reporter was
prepared by deletion of the AP-1 site of the−296HMAT-Luc reporter.
We also used the 2× AP-1-Luc constructed by introducing two copies
of IL-8 AP-1 site in front ofminimal IL-8 promoter [21]. Jurkat and SLB-
1 cells were transfected with the appropriate reporter and effector
plasmids using electroporation. After 24 h, the cells were washed in
PBS and lysed in reporter lysis buffer (Promega). Lysates were assayed
for reporter gene activity with the dual luciferase assay system
(Promega). Luciferase activities were normalized relative to the
Renilla luciferase activity from phRL-TK.
2.8. Small interfering RNA (siRNA)
To repress JunD, predesigned double-stranded siRNA (ON-TARGET
plus SMART pool; Dharmacon Inc., Lafayette, CO, USA) was used. A
siCONTROL non-targeting siRNA pool (Dharmacon Inc.) was used as a
negative control. All siRNA transfections were performed using a
MicroPorator MP-100 (Digital Bio Technology, Seoul, Korea) accord-
ing to the instructions supplied by the manufacturer for optimization
and use.
2.9. Preparation of nuclear extracts and electrophoretic mobility shift
assay (EMSA)
Cell pelletswere swirled to a loose suspension and treatedwith lysis
buffer [0.2 ml, containing in10 mMHEPES (pH7.9), 10 mMKCl, 0.1 mM
EDTA, 0.1 mMEGTA, 2 mMAEBSF and 1 mMDTT]with gentlemixing at
4 °C. After 10 min, NP40 was added to a ﬁnal concentration of 0.6% and
the solutionwas centrifuged immediately at 1000 rpm for 5 min at 4 °C.
The supernatants were removed carefully and the nuclear pellets were
diluted immediately by the additionofNP40-free lysis buffer (1 ml). The
nuclei were then recovered by centrifugation at 1000 rpm for 5 min at
4 °C. Finally, the remaining pellets were suspended on ice in an
extraction buffer [20 mM HEPES (pH 7.9), 0.4 M NaCl, 1 mM EDTA,
1 mM EGTA, 1 mM DTT, 2 mM AEBSF, 33 μg/ml aprotinin, 10 μg/ml
leupeptin, 10 μg/ml E-64 and 10 μg/ml pepstatin A] for 30 min to obtain
the nuclear fraction. All fractions were cleared by centrifugation for
15 min at 15000 rpm. Transcription factors bound to speciﬁc DNA
sequences were examined by EMSA as described previously [22]. To
examine the speciﬁcity of the probe, we preincubated unlabeled
competitor oligonucleotides with nuclear extracts for 15 min before
incubation with probes. The probes or competitors used were prepared
by annealing the sense and antisense synthetic oligonucleotides as
follows: for the AP-1 element of the MMP-7 gene, 5′-GATCTCAAAT-
GAGTCACCTAT-3′; for the nuclear factor-κB (NF-κB) element of the IL-2
receptor α chain (IL-2Rα) gene, 5′-GATCCGGCAGGGGAATCTCCCTCTC-
3′; and for the AP-1 element of the IL-8 gene, 5′-GATCGTGATGACT-CAGGTT-3′. The oligonucleotide 5′-GATCTGTCGAATGCAAATCACTA-
GAA-3′, containing the consensus sequence of the octamer binding
motif, was used to identify speciﬁc binding of the transcription factor
Oct-1. The underlined sequences above are the NF-κB, AP-1 and Oct-1
binding sites, respectively. To identify transcription factors in the DNA–
protein complex shown by EMSA, we used antibodies speciﬁc for
various AP-1 family proteins, including c-Fos, FosB, Fra-1, Fra-2, c-Jun,
JunB and JunD (Santa Cruz Biotechnology, Santa Cruz, CA, USA), to elicit
a supershift DNA–protein complex formation. These antibodies were
incubated with the nuclear extracts for 45 min at room temperature
before incubation with radiolabeled probe.
2.10. Cell invasion assay
ACEA electrosensing×16 microtiter plates were coated with
Matrigel (BD Biosciences, San Jose, CA, USA) diluted 1:25 in starvation
media. SLB-1 cells were seeded at 3×105 cells/ml in 100 μl of serum-
free medium with or without a goat polyclonal MMP-7 neutralizing
antibody or a normal goat IgG (R&D systems, Inc., Minneapolis, MN,
USA) in the upper chamber with 8 μm pore size, and the lower
chamber contained 10% serum. The ACEA plate was connected to the
ACEA Device Station at 37 °C, and SLB-1 cells that invaded through
Matrigel weremonitored every 15 min in real time by an ACEA Sensor
Analyzer for 24 h and quantitated using ACEA RT-CES Integrated
Software.
2.11. Statistical analysis
Data were expressed as mean±SD. Differences between groups
were examined for statistical signiﬁcance using the unpaired Student's
t-test. A p values less than 0.05 denoted the presence of a statistically
signiﬁcant difference.
3. Results
3.1. MMP-7 expression in HTLV-1-infected T-cell lines and primary ATL
cells
First, we examined the expression of Tax in various human T-cell
lines (Fig. 1A). HTLV-1-transformed T-cell lines (MT-2 and SLB-1)
expressed high levels of Tax protein. In ATL-derived T-cell lines, MT-1
and TL-OmI cells did not express Tax protein. HLN-ATL-O cells
expressed Tax but less than MT-2 and SLB-1 cells. We next examined
the expression of MMP-7 at mRNA level in various human T-cell lines
by RT-PCR. As shown in Fig. 1A, compared to uninfected T-cell lines,
HTLV-1-infected T-cell lines consistently expressed MMP-7 mRNA.
Especially, HTLV-1-transformed T-cell lines expressed MMP-7 mRNA
at high level. We also examined the localization of MMP-7 protein in
SLB-1 and MT-2 cells by immunoﬂuorescent staining and confocal
microscopy (Fig. 1B). MMP-7 was detectable in the cytoplasm of
immunopositive SLB-1 and MT-2 cells.
To substantiate HTLV-1 control of MMP-7 expression, studies were
performed using a parental TY8-3 cell line and TY8-3 cells infected
with HTLV-1 (TY8-3/MT-2). As shown in Fig. 1C, TY8-3/MT-2 cells
demonstrated strong expression of Tax mRNA. We next examined the
expression of MMP-7 in these cells. Cognate MMP-7 expression was
signiﬁcantly enhanced in TY8-3/MT-2 cell line, while MMP-7
expression in the parental line was negative (Fig. 1C). These results
suggest that infection of TY8-3 with HTLV-1 induces expression of
MMP-7.
Furthermore, we examined the mRNA expression of MMP-7 in
primary ATL cells freshly isolated from patients in comparison with
normal PBMCs in resting and activated conditions (Fig. 2A). Primary
ATL cells consistently expressed MMP-7 at levels much higher than
normal PBMCs. MMP-7 expression was induced in response to PHA.
To investigate the expression of MMP-7 in situ, we performed
Fig. 1. Expression ofMMP-7 in HTLV-1-infected T-cell lines. (A) Expression ofMMP-7 and Tax in HTLV-1-infected T-cell lines. RT-PCR analysis was carried out for MMP-7 and β-actin (loading
control). Western blot analysis was performed for Tax and actin. Lt-4 monoclonal antibody detected a 40 kDa molecule (p40) in SLB-1 and HLN-ATL-O cells, and p40 and p68 in MT-2 cells.
(B) Immunoﬂuorescence imagesof SLB-1andMT-2cells forMMP-7. SLB-1andMT-2cellswere immunostainedwithantibody that speciﬁcally recognizeMMP-7, followedby stainingwithAlexa
Fluor 488-labeled goat anti-mouse IgG (green) or Alexa Fluor 546-labeled goat anti-rabbit IgG (red), and counterstainedwithHoechst 33342 (nuclei stained in blue).MMP-7 is detectable in situ
in thecytoplasmofSLB-1andMT-2cells. (C)ComparisonofTY8-3cells andavirally-transformedcell line.RT-PCRanalysis formRNAexpressionofTaxandMMP-7 inTY8-3andTY8-3/MT-2cells.
Expression of β-actin was used as a control.
Fig. 2. Expression ofMMP-7 in primary ATL cells. (A) RT-PCR analysis for expression ofMMP-7 in normal PBMCs and primary ATL cells. Normal PBMCswere treatedwith PHA for 48 h
(PHA-PBMCs). Normal PBMCs from healthy donors (n=2), PHA-PBMCs (n=1) and freshly isolated primary ATL cells (N90% leukemic cells) from patients with acute type ATL
(n=9) were examined as indicated. (B) Immunohistochemical staining of MMP-7 in ATL lymph nodes. Tissue sections from ATL lymph nodes (n=6) and normal lymph nodes
(n=2)were stained with anti-MMP-7 antibody. Tissue sections were counterstained usingmethyl green. The primary antibody shows red staining ofMMP7 in imagewhilst nucleus
was stained green with methyl green. Representative results from two ATL patients and one normal lymph node. Original magniﬁcation: ×400.
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nodes (n=6). Representative results are shown in Fig. 2B. ATL cells
were positive for MMP-7 in all the tissue samples examined (Fig. 2B),
although the staining intensity varied from case to case. MMP-7
expression was weak in normal lymph nodes (n=2) (Fig. 2B).
3.2. Tax-dependent expression of MMP-7
The tax gene product is the primary viral transactivator protein that
modulates the expression of both viral and cellular genes. To examine
whether Tax induces MMP-7 expression, we used JPX-9 cells; this is a
Jurkat subline that carries the tax gene under the control of the
metallothionein gene promoter [14]. As shown in Fig. 3A, treatment of
JPX-9 cellswith CdCl2 induced the expression of Tax.MMP-7mRNAwas
also induced in CdCl2-treated JPX-9 cells. In contrast, this treatment did
not show any effect in Jurkat cells (Fig. 3B).
To test the effect of Tax onMMP-7 expression at the transcriptional
level, we further performed the luciferase reporter assays in Jurkat
cells using a MMP-7 promoter-luciferase reporter plasmid [20]. There
are one AP-1 site and two Tcf sites in the MMP-7 promoter (Fig. 4A).
As shown in Fig. 4B, cotransfection of an expression vector for Tax
strongly activated the MMP-7 promoter in Jurkat cells after 24 h,
indicating that Tax can directly activate the MMP-7 promoter.
To narrow down the transactivation-relevant signaling pathways,
Tax mutants M22 and 703 [16] were cotransfected along with the
MMP-7 promoter construct, followed by determination of luciferase
activities. Tax M22 has an amino acid substitution at codons 130 and
131 from Thr–Leu to Ser-Ala. Tax 703 has an amino acid substitution
at codons 319 and 320 from Leu–Leu to Arg–Ser, which is equivalent
to mutant M47 [23]. Tax M22 effectively activates cyclic AMP
response element (CRE), which mediates the Tax-dependent activa-
tion of the HTLV-1 long terminal repeat, but not the NF-κB element. In
contrast, Tax 703 activates the NF-κB element but does not affect CRE.
Tax M22 slightly activated the MMP-7 promoter (Fig. 4B). Tax 703
clearly activated the MMP-7 promoter, but the levels were less than
wild type Tax (Fig. 4B). On the other hand, the two mutants together
activated MMP-7 promoter. These results suggest that Tax activates
the MMP-7 promoter in NF-κB- and CRE-dependent manners. In this
context, it was intriguing to examine whether exogenous expressionFig. 3. Tax induces MMP-7 expression. JPX-9 cells (A) and Jurkat cells (B) were treated
with or without 20 μM of CdCl2 for the indicated time periods. RT-PCR was carried out
for MMP-7 and β-actin (loading control). Control indicates MT-2 cells (positive
control). Western blot analysis was also performed for Tax and actin (loading control).of subunits of NF-κB or CRE binding protein (CREB) activates the
MMP-7 promoter. However, introduction of the NF-κB p65 subunit or
CREB failed to activate the MMP-7 promoter (data not shown), and
the MMP-7 promoter sequence between −296 and +35 bp did not
include sequences suggestive of sites for binding to NF-κB and CREB,
suggesting that activation of MMP-7 promoter by Tax is not directly
mediated by the NF-κB and CRE pathways.
We have previously reported that Tax activates the AP-1 site via a
mechanism different from the NF-κB and CRE-like elements in a T-cell
line and the coexpression of TaxM22 and Tax 703 can activate the AP-1
site [24]. We conﬁrmed these results. Tax 703 activated the AP-1 site,
but the levels were less than wild type Tax, and Tax M22 slightly
activated it (Fig. 4C). TheMMP-7promoter has a canonical AP-1 site (5′-
TGAGTCA-3′) located between −67 and −61 [25]. To determine the
precise regions of the MMP-7 promoter necessary for Tax-mediated
activation, AP-1 site deletionmutantwas constructed (Fig. 4D). Deletion
of the AP-1 site abolished the Tax-mediated activation of the MMP-7
promoter (Fig. 4D). In contrast, mutation of both the−194 Tcf site and
the−109 Tcf site had no effect on the Tax-mediated activation of the
MMP-7 promoter (Fig. 4E).
3.3. HTLV-1 and Tax elicit JunD binding to the MMP-7 AP-1 element
In the next step, we determined whether HTLV-1 infection
induced AP-1 binding to the AP-1 element in the MMP-7 promoter.
EMSA was performed with double-stranded oligonucleotides repre-
senting the AP-1 element. Protein complexes bound to the AP-1 site
were detected with nuclear extracts derived from all HTLV-1-infected
T-cell lines examined, but not the control uninfected T-cell lines
(Fig. 5A). Of note, no differences in binding to the octamer motif on
DNA were noted in the absence or presence of HTLV-1 infection.
The speciﬁcity of DNA–protein complex formation was deter-
mined by competition studies with unlabeled competitors. As
expected, a “cold” MMP-7 AP-1 double-stranded oligonucleotide or
an AP-1 site from the IL-8 promoter effectively competed with the
labeled probe and eliminated binding of nuclear extracts from SLB-1
cells in a dose-dependent manner (Fig. 5B). The unlabeled consensus
NF-κB site from the IL-2Rα promoter could not compete with the
labeled probe (Fig. 5C, lanes 1 and 4). The exact composition of the
transcription factor DNA–protein complexes in HTLV-1-infected T-
cells was ascertained by supershift analysis. Supershift reactions
performed using SLB-1 nuclear extracts revealed that JunD was the
predominant component of the AP-1 complexes in SLB-1 (Fig. 5C, lane
11).
Antibodies against c-Fos and c-Jun induced supershifted complexes
in Jurkat cells stimulated by PMAplus ionomycin, using theAP-1 site of
MMP-7 gene as a probe (Fig. 5D, lanes 6 and 10). This indicated that at
least c-Fos and c-Jun antibodies are also functional in this assay when
the complexes contain sufﬁcient amount of appropriate protein.
We also examined the binding activity to an AP-1 site in PBMCs.
Protein complexes bound to the AP-1 elementwere detected in nuclear
extracts from PBMCs stimulated with PHA, but not normal PBMCs
(Fig. 6A). Antibodies against Fra-2 and JunD induced a supershifted
complex in PHA-stimulated PBMCs (Fig. 6A, lanes 11 and 14). The AP-1
complexeswere alsodetected in nuclear extracts fromprimaryATL cells
(Fig. 6B). In all tested nuclear extracts, the addition of antibody against
JunD induced a new slow-migrating complex as observed in SLB-1 cells
(Fig. 6B, lanes 11, 16 and 21). In addition, antibodyagainst c-Jun induced
a weak supershifted complex in ATL 1 (Fig. 6B, lane 9).
We also observed that Tax expression alone elicited binding to the
MMP-7 AP-1 probe in nuclear extracts from JPX-9 cells (Fig. 7A).
Induction of Tax expression resulted in the formation of complexes
with the MMP-7 probe within 48 h, but no differences in binding to
the Oct-1 on DNA were noted in the absence or presence of CdCl2.
Supershift analyses performed with JPX-9 cells indicated that JunD
was the major AP-1 factor induced after 72-h treatment with CdCl2
Fig. 4. Tax activates the MMP-7 promoter via AP-1. (A) A diagram of the human MMP-7 promoter is shown. Indicated are positions relative to the transcription start site of the two
consensus Tcf binding sites as well as the position of the AP-1 site. Jurkat cells were transfected with either−296HMAT-Luc (B) or 2× AP-1-Luc (C) together with expression vector
for HTLV-1 Tax (Tax WT), Tax M22, Tax 703 or empty vector alone or the combination of Tax M22 and Tax 703 using electroporation. Tax transactivation of the AP-1 site deletion
(D) or the two Tcf sites mutation (E) of the MMP-7 promoter. The indicated promoter constructs were transfected in the presence of the indicated amounts of Tax. Cells were
harvested 24 h post-transfection and luciferase activity was measured with a luminometer. The results are expressed as fold induction by Tax or Tax mutants relative to the vector
alone (B and C) or expressed relative to activity of cells transfected with −296HMAT-Luc and empty vector, which was deﬁned as 1 (D and E). Data are mean±SD of three
independent transfection experiments.
Fig. 5. HTLV-1 infection is associated with binding of JunD to the AP-1 site in MMP-7 promoter. (A) Nuclear extracts (5 μg) from control uninfected and HTLV-1-infected T-cell lines
were incubated with the indicated labeled double-stranded DNA probes in EMSA reactions. (B) Nuclear extracts from SLB-1 cells were subjected to competition analysis with a 100-,
50-, 25-, 12.5-fold molar excess of unlabeled double-stranded oligonucleotides representing the MMP-7 AP-1 site (lanes 2–5) or an AP-1 site from the IL-8 promoter (lanes 7–10).
(C and D) Nuclear extracts from SLB-1 cells (C) and Jurkat cells stimulated by PMA (20 ng/ml) plus ionomycin (2 μM) (PMAI) for 4 h (D) were subjected to competition analysis with
a 100-fold molar excess of unlabeled double-stranded oligonucleotides representing the MMP-7 AP-1 site (lane 2 in C and lane 3 in D), an AP-1 site from the IL-8 promoter (lane 3 in
C and lane 4 in D) or a consensus NF-κB site from the IL-2Rα promoter (lane 4 in C and lane 5 in D). The indicated unlabeled oligonucleotides were incubatedwith nuclear extracts for
15 min prior to binding reactions. Nuclear extracts were also subjected to supershift assays with either no antibody (lane 1 in C and lane 2 in D) or the indicated antibodies (Ab)
(lanes 5–11 in C and lanes 6–12 in D). The antibodies were incubated with nuclear extracts for 45 min prior to binding reactions. Arrows: speciﬁc complexes, arrowhead: the DNA
binding complex supershifted by the antibody.
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Fig. 6. Components of AP-1 in PBMCs stimulated with PHA and PBMCs from patients with ATL. Normal PBMCs were treated with PHA for 48 h (PHA-PBMCs). Nuclear extracts were
prepared from PHA-PBMCs and PBMCs from 3 healthy volunteers (A) or 3 patients with ATL (B). The extracts from PHA-PBMCs and primary ATL cells were treated with antibodies
(Ab) against the indicated AP-1 proteins and incubated with an AP-1 site probe derived from theMMP-7 gene in the absence or presence of the indicated oligonucleotides. Arrows:
speciﬁc complexes, arrowhead: the DNA binding complex supershifted by the antibody.
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HTLV-1 infection and Tax expression resulted in binding of JunD
protein to the AP-1 element of the MMP-7 promoter.
3.4. JunD mediates MMP-7 activation by Tax
To conﬁrm the participation of JunD in the induction of MMP-7 by
Tax, we examined whether the activation of MMP-7 promoter could
be altered by a dominant negative mutant JunD (DN-JunD). This DN-
JunD protein lacks a functional transactivation domain [17]. Jurkat
cells were cotransfected with the MMP-7 reporter construct and with
either the DN-JunD expression vector or empty vector in the presence
or absence of Tax expression vector. As shown in Fig. 8A, activation ofFig. 7. Tax-induced AP-1 binding activity. (A) Nuclear extracts from JPX-9 cells treated w
indicated probes. (B) The extracts from JPX-9 cells treated with CdCl2 for 72 hwere treated w
an AP-1 site probe derived from theMMP-7 gene in the absence (lanes 1 and 5–11) or presenc
the DNA binding complex supershifted by the antibody.the MMP-7 promoter by Tax was inhibited by DN-JunD. Furthermore,
SLB-1 cells were cotransfected with the MMP-7 reporter construct
and the DN-JunD expression vector. As shown in Fig. 8B, DN-JunD
inhibited the MMP-7 promoter activity in a dose-dependent manner.
To further investigate the role of JunD protein in the Tax-mediated
stimulation of MMP-7, Jurkat cells were cotransfected with the MMP-
7 reporter construct and a vector (JunD/EB1) that drives the
expression of a JunD protein in which the JunD dimerization domain
is replaced with the dimerization domain from the Epstein–Barr virus
EB1 transcription factor [19]. This mutant JunD protein can form
transcriptionally active homodimers, but cannot form dimers with
endogenous wild type JunD, Fra-2 or FosB. The expression of JunD/EB1
substantially enhancedMMP-7 promoter function, generating a 3-foldith or without CdCl2 (20 μM) for the indicated time periods were incubated with the
ith antibodies (Ab) against the indicated AP-1 proteins (lanes 5–11) and incubated with
e (lanes 2–4) of the indicated oligonucleotides. Arrows: speciﬁc complexes, arrowhead:
Fig. 8. JunD mediates Tax-induced MMP-7 activation. (A) Jurkat cells were cotransfected with the −296HMAT-Luc together with Tax expression, a dominant negative JunD
expression (DN-JunD) or an empty vector. (B) SLB-1 cells were cotransfected with the −296HMAT-Luc together with various amounts of DN-JunD. (C) Jurkat cells were
cotransfected with −296HMAT-Luc together with Tax expression vector, a pCMV5-derived vector carrying a JunD/EB1 fusion gene or an empty vector. (D) Jurkat cells were
cotransfected with −296HMAT-Luc together with Tax expression, a JunD coding sequence carrying a Ser to Ala mutation at Ser100 (JunD/S100A) or an empty vector. Cells were
harvested 24 h post-transfection and luciferase activity was measured with a luminometer. The results are expressed as fold induction by Tax or JunD mutants relative to the vector
alone (A, C and D) or expressed relative to activity of cells transfected with −296HMAT-Luc alone, which was deﬁned as 100 (B). Data are mean±SD of three independent
transfection experiments.
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control empty expression vector (Fig. 8C). Furthermore, we examined
whether JunD modiﬁes the Tax-mediated MMP-7 promoter activity.
The MMP-7 reporter construct was cotransfected with a JunD/EB1
expression vector in the presence of Tax coexpression. As expected,
the expression of JunD/EB1 increased the activity of the promoter in
the presence of Tax coexpression (Fig. 8C).
The transcriptional activity of JunD can be regulated by phosphor-
ylation of Ser residues located in the NH2-terminal domain [26,27].
Most notable in this regard are regulatory phosphorylations occurring
on Ser90 and Ser100 within the transactivation domain [28].
Therefore, we next tested whether Tax induces the phosphorylation
of the JunD protein in JPX-9 cells. Western blot analysis of the cell
lysates identiﬁed the phospho-JunD protein in CdCl2-treated JPX-9
cells (Fig. 9A). To further study the functional role of JunD Ser100
phosphorylation in the Tax-stimulated MMP-7 induction, a plasmid
encoding a modiﬁed JunD protein, in which the Ser100 residue was
replaced by Ala (JunD/S100A), was introduced in the presence or
absence of Tax into Jurkat cells. Mutation of Ser to Ala in AP-1 proteins
prevents phosphorylation of the mutated residue [29]. As shown in
Fig. 8D, overexpression of JunD/S100A had no effect on the activity of
the MMP-7 reporter construct. However, when cells were cotrans-
fected with JunD/S100A and Tax, JunD/S100A protein inhibited the
Tax-induced MMP-7 reporter construct activity.
Since JNK1/2 and ERK1/2 were reported previously to phosphor-
ylate JunD [30], we examined whether JNK1/2 and ERK1/2 mediate
the Tax stimulation of MMP-7. We therefore assessed JNK1/2 and
ERK1/2 phosphorylation by Western blot analysis with antibodies
that speciﬁcally recognize the phosphorylated Thr183 and Tyr185 of
JNK1/2 and Thr202 and Tyr204 of ERK1/2. The results in Fig. 9A show a
strong activation of JNK1/2 and ERK1/2 in JPX-9 cells treated with
CdCl2, as evidenced by strong phospho-c-Jun, JunD, JNK1/2 and ERK1/
2 signals. The amount of total JNK1/2 and ERK1/2 remained the same
regardless of treatment, as shown by the use of pan JNK1/2 and ERK1/
2 antibodies, which recognize total JNK1/2 and ERK1/2. These ﬁndingsindicate that Tax activates JNK1/2 and ERK1/2. We used SP600125, an
inhibitor of JNK1/2 and PD98059, an inhibitor of mitogen-activated
protein kinase/ERK kinase1/2, an upstream activator of ERK1/2.
Treatment with SP600125 and PD98059 inhibited the phosphoryla-
tion of JunD in MT-2 cells. MMP-7 expression was also inhibited when
the cells were treated with SP600125 and PD98059 (Fig. 9B). These
results indicate that activation of JNK1/2 and ERK1/2 is required for
MMP-7 expression. SP600125 and PD98059 are chemical inhibitors,
and thus their target speciﬁcity may be questionable. Therefore, siRNA
for JunD was used to examine the role of JunD activation in the signal
transduction pathway leading to MMP-7 expression by Tax. siRNA
speciﬁcally inhibited the expression of JunD at mRNA and protein
levels (Fig. 9C). Fig. 9C also shows that MMP-7 mRNA expression was
inhibited by siRNA for JunD, conﬁrming that JunD is important in Tax-
induced MMP-7 expression.
The functional signiﬁcance ofMMP-7 and JunDwas ﬁnally examined
using invasion assay. In this model, SLB-1 cells markedly invaded
through Matrigel-coated plates compared with Jurkat cells (data not
shown). A role for MMP-7 in invasion was shown by the inhibition of
invasion by addition of neutralizing MMP-7 antibody in a dose-
dependentmanner (Fig. 10A). In contrast, normal goat IgG had no effect
on SLB-1 cell invasion (Fig. 10A, bottom panel). JunD knockdown also
caused a marked decrease in SLB-1 cell invasion (Fig. 10B), suggesting
that JunD-mediated MMP-7 induction was involved in invasion.
4. Discussion
In the present study, we examined MMP-7 expression in HTLV-1-
infected T-cell lines and primary ATL cells, and compared the
expression level with that in uninfected T-cell lines and normal
PBMCs. The results showed that HTLV-1-infected T-cell lines and ATL
cells expressed signiﬁcantly higher levels of MMP-7 than did any
other cell. The results also showed that the viral oncoprotein Tax
induced MMP-7 expression in T cells. The interest in the regulation of
thisMMP is based on its implications in cancer progression [31]. Based
Fig. 9. Activation of JNK1/2 and ERK1/2 is required for MMP-7 expression. (A)Western blot of cell extracts from JPX-9 cells treated with 20 μMof CdCl2 for the indicated time periods
using the indicated antibodies. (B) MT-2 cells were treated with SP600125 (20 μM) or PD98059 (10 μM) for 48 h. Total RNA was isolated from each cell and the expression levels of
MMP-7 and β-actin (loading control) mRNAweremeasured by RT-PCR (right panels). Histograms indicate the relative density data of MMP-7mRNA by densitometric analysis of the
bands shown in the top panel normalized to β-actin mRNA (bottom panel). Cell lysates were also analyzed by Western blot using the indicated antibodies (left panels). (C) RT-PCR
analysis of JunD, MMP-7 and β-actin (loading control) mRNA expression levels 48 h after transfection with either siRNA for JunD or siCONTROL non-targeting siRNA pool (control)
(right panels). Histograms indicate the relative density data of JunD and MMP-7 mRNA by densitometric analysis of the bands shown in the top and middle panels normalized to β-
actin mRNA (bottom panel). JunD protein levels were determined by Western blot analysis (left panels).
Fig. 10. Neutralization of MMP-7 using anMMP-7 polyclonal antibody (A) and JunD knockdown (B) inhibited SLB-1 cell invasion. (A) SLB-1 cells were seeded with or without a goat
polyclonal MMP-7 neutralizing antibody (top and bottom panels) or with normal goat IgG (bottom panel) in the upper chamber for 24 h. (B) SLB-1 cells were transfected with either
JunD or control siRNA and then incubated for 24 h. Thereafter, SLB-1 cells were seeded in the upper chamber for 24 h. Cell invasion was monitored using RT-CES system for SLB-1
cells. Data are mean±SD of three independent invasion experiments in a period of 24 h. *Pb0.05 vs. control.
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members of the ETS family of proteins are known to regulate MMP-7
gene expression. For example, cotransfection of β-catenin, c-Jun and
PEA3 ETS transcription factor induces promoter activity [20,32].
We also explored the mechanism of Tax-mediated MMP-7 ex-
pression in T cells. Induction of high levels of MMP-7 promoter
activity by Tax was dependent on an intact AP-1 site. Tax can activate
AP-1-responsive genes with different function. Unlike the wild type
Tax, neither of the mutant M22 and 703 was able to fully activate the
promoter, suggesting that either NF-κB or CREB pathway is insufﬁ-
cient for the transactivation of MMP-7 promoter. Recently, Tax has
been reported to transactivate the osteopontin promoter through AP-
1 site [33]. In this case, Tax-mediated osteopontin activation was also
partially abrogated either by mutation introduced in NF-κB or CREB
pathway. Thus, Tax could indirectly control the expression of AP-1-
responsive genes through NF-κB or CREB dependent AP-1 activation.
Tax induced binding of JunD to the AP-1 element of the MMP-7
promoter. It has been previously reported that JunD is the predom-
inant Jun family protein expressed in HTLV-1-infected T-cell lines and
primary ATL cells [34]. In this study, we provide evidence that JunD
functions in T cells to regulate the transcription of MMP-7 gene.
We demonstrated that overexpression of the homodimeric JunD/
EB1 enhanced MMP-7 promoter activity in the absence or presence of
Tax; in contrast, the expression of a dominant negative JunD protein in
Jurkat cells inhibitedMMP-7 promoter function in the presence of Tax.
We also observed that a siRNA for JunD could substantially reduce
MMP-7 expression in HTLV-1-infected T-cell lines. Taken together,
these data indicate that JunD is a vital component of the transcriptional
machinery that regulates MMP-7 expression in HTLV-1-infected T
cells.
The NH2-terminus of JunD contains 3 mitogen-activated protein
kinase target residues (Ser90, Ser100 and Thr117) phosphorylated by
both the JNK1/2 and the ERK1/2 pathways [18,30,35]. The transcrip-
tional activity of JunD can be regulated by phosphorylation of Ser
residues [26,27]. In the present study, Tax activated JNK1/2 and ERK1/
2, leading to phosphorylation of Ser100 in the JunD protein.
Phosphorylation of JunD and expression of MMP-7 could be reduced
by inhibitors of JNK1/2 and ERK1/2 in an HTLV-1-infected T-cell line.
JunD phosphorylation at Ser100 was necessary for stimulation of Tax-
mediated MMP-7 gene transcription. We therefore propose that Tax-
mediated MMP-7 gene transcription in T cells requires both JNK1/2
and ERK1/2 phosphorylation of JunD.
The AP-1 complex induced by Tax and in an HTLV-1-infected T-cell
line contained JunD, but the antibody against JunD did not completely
induce the supershifted complex. Therefore, the involvement of
transcription factors other than JunD is likely to be essential for the
transcription of MMP-7 gene through an AP-1 site. The activating
transcription factor (ATF) family represents a large group of basic-region
leucine zipper transcription factors. ATF family members form homo-
dimers or heterodimers with other basic-region leucine zipper contain-
ing proteins such as the AP-1 [36].We are investigating the involvement
of ATF family members in Tax-induced MMP-7 transcription.
It is known that Tax expression diminishes after the early phase of
infection in human, probably due to immune surveillance. It is
possible that MMP-7 induction persists after the initial Tax activation.
Indeed, Tax-negative ATL-derived T-cell lines, MT-1 and TL-OmI, and
primary ATL cells expressed MMP-7, suggesting that Tax does not
fully explain ATL pathobiology. Thus, cells no longer expressing Tax
continue to show constitutively activated AP-1, resulting in aberrant
MMP-7 expression.
The HTLV-1 basic leucine zipper factor gene HBZ is located in the 3′
portion of the provirus and is maintained in ATL cells [37,38]. HBZ
plays an important role in HTLV-1 infectivity and persistence [39].
HBZ heterodimerizes with either JunD or JunB and transactivates
expression of AP-1 target genes [40]. JunD/HBZ heterodimers may
induce upregulation of MMP-7 expression in ATL.What would HTLV-1 gain from upregulation of MMP-7 expres-
sion? It is possible that HTLV-1-induced activation of MMPs enhances
the spread of the virus or virus-infected cells and ATL cells, through
the actions of these proteins on reducing the matrix barrier of tissues.
In otherwords, MMP-7may underlie the invasive nature of ATL. A role
for MMP-7 in invasion was shown by the inhibition of SLB-1 cell
invasion by addition of neutralizing MMP-7 antibody.
In summary, we reported in this study that HTLV-1 Tax induces
MMP-7 expression in T cells and that this process is regulated in an
AP-1-dependent fashion. The in vivo relationship between dissemi-
nated ATL organ involvement and MMP-7 expression remains an
interesting question awaiting further research.
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